Chapter 1 Methodology and Scope
1.1 Information Procurement
1.1.1 Purchased database:
1.1.2 GVR's internal database
1.2 Research Methodology
1.3 Geographic Scope & Assumptions
1.4 Region-wise Market Calculation
1.4.1 Region-wise market: Base estimates
1.4.2 Global market: CAGR calculation
1.5 Region-based Segment Share Calculation
1.6 List of Secondary Sources

Chapter 2 Executive Summary
2.1 Market Snapshot

Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Market Size and Growth Prospects
3.2.1 Market driver analysis
3.2.1.1 Rise in importance and awareness of immunization across the globe
3.2.1.2 High predominance of chronic diseases
3.2.1.3 Technologic advancements in the types of vaccines
3.2.1.4 Increase in government and nongovernment funding.
3.2.2 Market restraint analysis
3.2.2.1 Cost of immunization
3.2.2.2 Lack of healthcare infrastructure
3.3 Penetration & Growth Prospect Mapping
3.4 Pediatric Vaccines - SWOT Analysis, by Factor (Political & legal, economic and technological)
3.5 Industry Analysis - Porter's
3.6 Pipeline Analysis

Chapter 4 Pediatric Vaccines Market: Type Estimates & Trend Analysis
4.1 Vaccines Market: Vaccine Type Movement Analysis
4.2 Monovalent Vaccines
4.2.1 Monovalent vaccines market, 2014 - 2025 (USD Billion)
4.3 Multivalent Vaccines
4.3.1 Multivalent vaccines market, 2014 - 2025 (USD Billion)

Chapter 5 Pediatric Vaccines Market: Technology Estimates & Trend Analysis
5.1 Pediatric Vaccines Market: Vaccine Technology Movement Analysis
5.2 Live Attenuated Vaccines
5.2.1 Live attenuated vaccines market, 2014 - 2025 (USD Billion)
5.3 Inactivated Vaccines
5.3.1 Inactivated vaccines market, 2014 - 2025 (USD Billion)
5.4 Subunit Vaccines
5.4.1 Subunit vaccines market, 2014 - 2025 (USD Billion)
5.5 Toxoid Vaccines
5.5.1 Toxoid vaccines market, 2014 - 2025 (USD Billion)
5.6 Conjugate Vaccines
5.6.1 Conjugate vaccines market, 2014 - 2025 (USD Billion)
5.7 Others
5.7.1 Other vaccines market, 2014 - 2025 (USD Billion)

Chapter 6 Pediatric Vaccines Market: Application Estimates & Trend Analysis
6.1 Pediatric Vaccines Market: Application Movement Analysis
6.2 Infectious Diseases
6.2.1 Infectious diseases market, 2014 - 2025 (USD Billion)
6.3 Cancer
6.3.1 Cancer market, 2014 - 2025 (USD Billion)
6.4 Allergy
6.4.1 Allergy market, 2014 - 2025 (USD Billion)

Chapter 7 Pediatric Vaccines Market: Regional Estimates & Trend Analysis, by Type & Application
7.1 Pediatric Vaccines Market Share by Region, 2015 & 2025
7.2 North America
7.2.1 North America vaccines market, 2014 - 2025 (USD Billion)
7.2.2 U.S.
7.2.2.1 U.S pediatric vaccines estimates and forecasts, 2014 - 2025 (USD Billion)
7.2.3 Canada
7.2.3.1 Canada pediatric vaccines estimates and forecasts, 2014 - 2025 (USD Billion)
7.3 Europe
7.3.1 Europe pediatric vaccines market, 2014 - 2025 (USD Billion)
7.3.2 Germany
7.3.2.1 Germany pediatric vaccines estimates and forecasts, 2014 - 2025 (USD Billion)
7.3.3 UK
7.3.3.1 UK pediatric vaccines estimates and forecasts, 2014 - 2025 (USD Billion)
7.4 Asia Pacific
7.4.1 Asia Pacific pediatric vaccines market, 2014 - 2025 (USD Billion)
7.4.2 China
7.4.2.1 China pediatric vaccines estimates and forecasts, 2014 - 2025 (USD Billion)
7.4.3 Japan
7.4.3.1 Japan pediatric vaccines estimates and forecasts, 2014 - 2025 (USD Billion)
7.4.4 India
7.4.4.1 India pediatric vaccines estimates and forecasts, 2014 - 2025 (USD Billion)
7.5 Latin America
7.5.1 Latin America pediatric vaccines market, 2014 - 2025 (USD Billion)
7.5.2 Brazil
7.5.2.1 Brazil pediatric vaccines estimates and forecasts, 2014 - 2025 (USD Billion)
7.5.3 Mexico
7.5.3.1 Mexico pediatric vaccines estimates and forecasts, 2014 - 2025 (USD Billion)
7.6 MEA
7.6.1 MEA pediatric vaccines market, 2014 - 2025 (USD Billion)
7.6.2 South Africa
7.6.2.1 South Africa pediatric vaccines estimates and forecasts, 2014 - 2025 (USD Billion)

Chapter 8 Competitive Landscape
8.1 Strategy Framework
8.2 Market Participation Categorization
8.3 Company Profiles
8.3.1 GlaxoSmithKline plc (GSK)
8.3.1.1 Company overview
8.3.1.2 Financial performance
8.3.1.3 Product benchmarking
8.3.1.4 Strategic initiatives
8.3.2 Merck Sharp & Dohme Corp.
8.3.2.1 Company overview
8.3.2.2 Financial performance
8.3.2.3 Product benchmarking
8.3.2.4 Strategic initiatives
8.3.3 SANOFI
8.3.3.1 Company overview
8.3.3.2 Financial performance
8.3.3.3 Product benchmarking
8.3.3.4 Strategic initiatives
8.3.4 AstraZeneca
8.3.4.1 Company overview
8.3.4.2 Financial performance
8.3.4.3 Product benchmarking
8.3.4.4 Strategic initiatives
8.3.5 Pfizer, Inc.
8.3.5.1 Company overview
8.3.5.2 Financial performance
8.3.5.3 Product benchmarking
8.3.5.4 Strategic initiatives
8.3.6 Zydus Cadila
8.3.6.1 Company overview
8.3.6.2 Financial performance
8.3.6.3 Product benchmarking
8.3.6.4 Strategic initiatives
8.3.7 Indian Immunologicals Limited
8.3.7.1 Company overview
8.3.7.2 Financial performance
8.3.7.3 Product benchmarking
8.3.7.4 Strategic initiatives
8.3.8 Mitsubishi Tanabe Pharma Corporation
8.3.8.1 Company overview
8.3.8.2 Financial performance
8.3.8.3 Product benchmarking
8.3.8.4 Strategic initiatives
8.3.9 Serum Institute of India Pvt. Ltd.
8.3.9.1 Company overview
8.3.9.2 Financial performance
8.3.9.3 Product benchmarking
8.3.9.4 Strategic initiatives
8.3.10 Panacea Biotec
8.3.10.1 Company overview
8.3.10.2 Financial performance
8.3.10.3 Product benchmarking
8.3.10.4 Strategic initiatives
8.3.11 Sinovac Biotech Ltd.
8.3.11.1 Company overview
8.3.11.2 Financial performance
8.3.11.3 Product benchmarking
8.3.11.4 Strategic initiatives
8.3.12 Bio Med Pvt. Ltd.
8.3.12.1 Company overview
8.3.12.2 Financial performance
8.3.12.3 Product benchmarking
8.3.12.4 Strategic initiatives

List of Tables
TABLE 1 Country share estimation
TABLE 2 North America pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
TABLE 3 North America pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
TABLE 4 North America pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
TABLE 5 Percent of children aged 19-35 months receiving vaccination (2015)
TABLE 6 U.S. pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
TABLE 7 U.S. pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
TABLE 8 U.S. pediatric pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
TABLE 9 Decline rate in children's health (2017)
TABLE 10 Canada pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
TABLE 11 Canada pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
TABLE 12 Canada pediatric pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
TABLE 13 Europe pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
TABLE 14 Europe pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
TABLE 15 Europe pediatric pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
TABLE 16 Germany pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
TABLE 17 Germany pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
TABLE 18 Germany pediatric pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
TABLE 19 U.K. pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
TABLE 20 U.K. pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
TABLE 21 U.K. pediatric pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
TABLE 22 Asia Pacific pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
TABLE 23 Asia Pacific pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
TABLE 24 Asia Pacific pediatric pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
TABLE 25 China pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
TABLE 26 China pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
TABLE 27 China pediatric pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
TABLE 28 Japan pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
TABLE 29 Japan pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
TABLE 30 Japan pediatric pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
TABLE 31 India pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
TABLE 32 India pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
TABLE 33 India pediatric pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
TABLE 34 Latin America pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
TABLE 35 Latin America pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
TABLE 36 Latin America pediatric pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
TABLE 37 Brazil pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
TABLE 38 Brazil pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
TABLE 39 Brazil pediatric pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
TABLE 40 Mexico pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
TABLE 41 Mexico pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
TABLE 42 Mexico pediatric pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
TABLE 43 MEA pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
TABLE 44 MEA pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
TABLE 45 MEA pediatric pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
TABLE 46 South Africa pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
TABLE 47 South Africa pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
TABLE 48 South Africa pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
TABLE 49 List of Market Players

List of Figures
FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Value chain based sizing & forecasting
FIG. 4 QFD modeling for market share assessment
FIG. 5 Market summary
FIG. 6 Market trends & outlook
FIG. 7 Market segmentation & scope
FIG. 8 The global pediatric vaccines market, 2014-2025 (USD Billion)
FIG. 9 Market driver relevance analysis (Current & future impact)
FIG. 10 Worldwide immunization coverage: 2016 (in %)
FIG. 11 Market restrain relevance analysis (Current & future impact)
FIG. 12 Penetration & growth prospect mapping
FIG. 13 SWOT Analysis, by factor (Political & legal, economic and technological)
FIG. 14 Porter's Five Forces Analysis
FIG. 15 Pediatric vaccines market type outlook key takeaways
FIG. 16 Pediatric vaccines market: Application movement analysis
FIG. 17 Global monovalent pediatric vaccines market, 2014 - 2025 (USD Billion)
FIG. 18 Global multivalent pediatric vaccines market, 2014 - 2025 (USD Billion)
FIG. 19 Pediatric vaccines market technology outlook key takeaways
FIG. 20 Pediatric vaccines market: Technology movement analysis
FIG. 21 Global live attenuated pediatric vaccines market, 2014 - 2025 (USD Billion)
FIG. 22 Global inactivated pediatric vaccines market, 2014 - 2025 (USD Billion)
FIG. 23 Global subunit pediatric vaccines market, 2014 - 2025 (USD Billion)
FIG. 24 Global toxoid pediatric vaccines market, 2014 - 2025 (USD Billion)
FIG. 25 Global conjugate pediatric vaccines market, 2014 - 2025 (USD Billion)
FIG. 26 Global other pediatric vaccines market, 2014 - 2025 (USD Billion)
FIG. 27 Pediatric vaccines market application outlook: Key takeaways
FIG. 28 Pediatric vaccines market: Application movement analysis
FIG. 29 Global infectious diseases market, 2014 - 2025 (USD Billion)
FIG. 30 Global cancer market, 2014 - 2025 (USD Billion)
FIG. 31 Global allergy market, 2014 - 2025 (USD Billion)
FIG. 32 Regional market place: Key takeaways
FIG. 33 Pediatric vaccines market: Regional movement analysis
FIG. 34 North America pediatric vaccines market,2014 - 2025 (USD Billion)
FIG. 35 Measles Cases per Year (2010 - 2016)
FIG. 36 Europe pediatric vaccines market, 2014 - 2025 (USD Billion)
FIG. 37 Asia Pacific pediatric vaccines market, 2014 - 2025 (USD Billion)
FIG. 38 Latin America pediatric vaccines market, 2014 - 2025 (USD Billion)
FIG. 39 MEA pediatric vaccines market, 2014 - 2025 (USD Billion)
FIG. 40 Strategy framework
FIG. 41 Participant categorization